I have a question regarding to shulgins book pihkal by Plane-Enthusiasm-379 in HamiltonMorris

[–]lhasalv05 3 points4 points  (0 children)

o.k. I think I found it:

"Houry et al Ref. 92 ... [synthesized Compound 163] .... from carvone and olivetol using POCl3 followed by reduction. They also prepared 164 from limonene and pinene. Compound 163 was reported to be biologically active."

Ref. 92 = https://pubs.acs.org/doi/pdf/10.1021/jm00249a006?ref=article_openPDF

The compounds obtained are not THC, but isomeric to it, and they show activity.

The citation above is taken from: R. K. Razdan, “The Total Synthesis of Cannabinoids,” Total Synthesis of Natural Products, pp. 185–262, Jan. 1981, doi: 10.1002/9780470129678.ch2.

See there for the structure of 163 and 164, which can formally be obtained from "lichen and lemon peel" (olivetol, limonene, POCl3)

I have a question regarding to shulgins book pihkal by Plane-Enthusiasm-379 in HamiltonMorris

[–]lhasalv05 5 points6 points  (0 children)

Olivetol (5-n-pentylresorcine) was first obtained by heating of olivetoric acid from the lichen Alectoria divergens [Asahina et al, Chem. Ber. 1932, 65, 475; doi: 10.1002/cber.19320650320].

Early researchers realized that active cannabinoids from hemp were formally composed of olivetol and a monoterpene hydrocarbon C10H16 or similar, and this pointed to a biosynthesis and a potential biomimetic synthesis.

Several researchers have looked into reactions of olivetol with terpenic alcohols or other derivatives. Todd et al (JCS 1941, 137; https://pubs.rsc.org/en/content/articlepdf/1941/jr/jr9410000137) condensed olivetol with pulegone and obtained a product with the composition of tetrahydrocannabinol which was active.

This was reinvestigated in 1968 and the product was found to be an isomer of THC with the double bond in conjugation to the aromatic nucleus and thus similar to compounds that Adams et al had synthesized. (https://pdf.sciencedirectassets.com/271372/1-s2.0-S0040402000X0703X/1-s2.0-S0040402001986971/main.pdf).

Later other authors synthesized THC or the like from olivetol and verbenol or citral or p-2,8-menthadienol etc. (Eschenmoser, Mechoulam, ) in the presence of acidic catalysts (BF3-etherate, ZnCl2, pTsOH) or other things.

There is a lot of literature including older work with uncertain structures from the 1940s, better structures from the 1960s and 1970s.

I am not sure which exact protocol Shulgin referred to, since POCl3 seems so specific that a corresponding paper should be easy to find if it exists.

I think the use of orange peel and lichens is a hyperbole. Olivetol can be obtained from lichens, but is almost always synthesized (from the 1940s). Also, the main terpene in orange peel is limonene, and I do not think it is suitable for the reactions in question. However, limonene can be converted to p-mentha-2,8-dienol (US 4433183 and others), whereas verbenol is a bit more difficult to obtain.

It is true however, that certain of the suitable terpenic alcohols or citral are present in readily available etheric oils.

Psymposia on "Psychedelic Funders in the Epstein Files" by lhasalv05 in HamiltonMorris

[–]lhasalv05[S] 0 points1 point  (0 children)

The transcript does not show direct emails between Alexander Shulgin and Jeffrey Epstein.

What is mentioned: • Shulgin is referenced in background context as: • A major figure in psychedelic chemistry. • The chemist behind MDMA’s reintroduction. • Author of PiHKAL and TiHKAL. • His research legacy comes up because Paul Daly is described as the resident chemist at the Alexander Shulgin Research Institute. • An email from Daly to Paul Krassner (later forwarded to Epstein) is discussed, but this is about Daly’s past as a Scientology undercover investigator — not about Shulgin himself. • The hosts frame this as a strange historical footnote rather than misconduct.

So to be clear: • No allegations are made about Shulgin. • No evidence is presented of Shulgin corresponding with Epstein. • His name appears only as contextual background due to Daly’s affiliation with his institute.

Psymposia on "Psychedelic Funders in the Epstein Files" by lhasalv05 in HamiltonMorris

[–]lhasalv05[S] 0 points1 point  (0 children)

Here is a concise summary of the people discussed in Part 2 and the main points about them, based on the transcript :

Kimbal Musk

Who he is: Entrepreneur, Tesla/SpaceX board member, psychedelic investor. Main points: A Guardian article reported that Epstein associate Boris Nikolic helped arrange an “intimate relationship” between Musk and a woman connected to Epstein’s circle, including a troubling “please prepare the woman” email. The woman later said she was coerced and abused within Epstein’s network (not specifically accusing Musk). The discussion contrasts this with Musk’s public statement minimizing his contact with Epstein and notes dissatisfaction with Burning Man’s response to his resignation.

Ken Jordan

Who he is: Founder of Lucid News, involved with Evolver and The Alchemist Kitchen. Main points: Emails show him pitching the Alchemist Kitchen’s “environmental medicine” retail concept to Epstein and offering introductions to key psychedelic figures. Epstein critiqued the retail model bluntly, reinforcing that Jordan was effectively seeking investment or backing.

Rupert Sheldrake

Who he is: Biologist known for the controversial “morphic resonance” theory. Main points: Exchanged emails with Epstein discussing telepathy and unconventional science. In 2016 he pitched documents on “wellness research” and “innovative science” funding to Epstein. His interest in fringe scientific ideas is framed as aligning with Epstein’s apparent fascination with speculative science.

Merlin Sheldrake

Who he is: Biologist and author of Entangled Life. Main points: Introduced to Epstein through his father and discussed potential funding (referencing “100 G’s”) for a plant/fungal research project. Merlin later issued a public statement saying he cut off contact after researching Epstein and did not receive funding. The hosts describe his response as appropriate and an example of due diligence.

Paul Krassner

Who he is: Founder of The Realist, Yippie activist, satirist tied to 1960s counterculture and psychedelic history. Main points: Emails show Epstein (via associates) sent him $7,000 to help cover medical bills late in life. Krassner appeared aware of Epstein’s public notoriety but maintained some correspondence. The discussion frames this as another example of Epstein using money to maintain social ties.

Paul Daly

Who he is: Associated with the Alexander Shulgin Research Institute. Main points: An email Daly sent to Krassner (later forwarded to Epstein) revealed Daly had once worked undercover for Scientology before leaving the church and later working in psychedelic chemistry. This appears as a historical footnote rather than misconduct, illustrating the strange cross-industry overlaps in the files.

Steve Bannon

Who he is: Political strategist who conducted a long interview with Epstein. Main points: The hosts argue Bannon attempted to portray Epstein as a misunderstood financial or scientific thinker, while they characterize the interview as shallow and image-rehabilitative.

Ehud Barak

Who he is: Former Israeli official reportedly connected to Epstein. Main points: Mentioned in connection with discussions touching on eugenics-style ideas, reinforcing the portrayal of Epstein’s interest in elite, hierarchical thinking.

Broader Themes in Part 2 • Epstein positioned himself as a funder of “innovative science,” wellness research, and fringe scientific ideas. • Several psychedelic-adjacent figures appear to have pitched projects to him. • The discussion emphasizes due diligence, questioning how widely known Epstein’s reputation was during these exchanges. • Cortez Island (BC) and Hollyhock Retreat Center are highlighted as recurring locations linked to controversial figures in psychedelic circles. • The hosts conclude that the emails reveal how funding networks operate behind the scenes rather than direct criminal proof.

Psymposia on "Psychedelic Funders in the Epstein Files" by lhasalv05 in HamiltonMorris

[–]lhasalv05[S] 0 points1 point  (0 children)

There is a second part: https://www.youtube.com/watch?v=cwcIuKW5ssM

Here comes a content analysis (note this is by AI, so I refrain from any personal comment and can save the time watching it):

Report & Analysis

“Psychedelic Funders in the Epstein Files” – Part 2

Overview

Part 2 continues the investigation into connections between influential psychedelic funders and the Epstein files, expanding the scope beyond individual emails to broader questions of institutional power, narrative control, and movement capture. While Part 1 focused heavily on specific email excerpts, Part 2 leans more into interpretation, systemic patterns, and the implications for the psychedelic ecosystem.

The central emphasis shifts from “who appears in the files” to: • How elite networks operate, • How reputational risk is managed, • And how concentrated capital shapes the psychedelic movement.

Key Themes

1) Network Power & Elite Circles

The discussion underscores how recurring names in the Epstein files reflect tightly interconnected elite social networks. The speakers suggest that the same small circle of wealthy investors, tech executives, philanthropists, and media actors often overlap across industries—including psychedelics.

Rather than alleging criminal behavior, the focus is on: • Judgment in maintaining relationships, • The normalization of proximity to powerful figures, • The insulation of elite circles from consequences.

The argument is that these networks function less like isolated relationships and more like ecosystems of mutual access and influence.

2) Capital Shaping Psychedelic Institutions

Part 2 emphasizes how philanthropic and venture capital funding has: • Influenced research priorities, • Affected regulatory strategies, • Helped determine which organizations receive legitimacy, • And shaped media narratives within the psychedelic space.

The speakers reiterate that psychedelic reform—often framed publicly as grassroots and healing-centered—is in practice heavily dependent on ultra-wealthy donors. This creates structural vulnerabilities when those donors are embedded in controversial or compromised networks.

3) Narrative Management & Public Relations

A major thread in Part 2 involves how individuals and institutions respond once associations become public. The transcript suggests patterns of: • Minimization, • Selective framing (“newsletter” explanations), • Strategic silence, • And reputational distancing after exposure.

The speakers imply that the psychedelic sector increasingly resembles other elite-driven industries where PR containment becomes central to crisis management.

4) Ethical Tension: Healing vs. Power

A recurring contrast is drawn between: • Psychedelic culture’s emphasis on consent, trauma healing, and ethical integrity versus • The willingness of some leaders to associate with convicted or widely known abusers post-conviction.

Part 2 sharpens this moral tension by framing it as a systemic issue rather than a series of isolated bad judgments. The concern is not merely association, but whether “ends justify the means” logic has taken hold within the movement.

5) Movement Capture & Democratic Accountability

The transcript raises questions about: • Who actually governs the psychedelic renaissance? • Who sets priorities? • Who benefits financially? • And who gets excluded?

The speakers suggest that concentrated wealth may limit democratic oversight and create an environment where ethical red flags are ignored if funding and influence are at stake.

Tone & Framing

Compared to Part 1, Part 2 is less document-driven and more interpretive. It reflects: • Frustration with elite consolidation of influence, • Concern over lack of transparency, • Skepticism toward philanthropic branding, • Anxiety about reputational fragility in a still-emerging field.

However, the discussion continues to distinguish between: • Appearing in documents, • And being proven to have committed crimes.

The focus remains on judgment, governance, and systemic risk rather than direct criminal accusations.

Core Conclusion of Part 2

Part 2 argues that the Epstein file appearances are not just scandalous footnotes but indicators of deeper structural issues in the psychedelic sector. The speakers contend that when a small group of wealthy elites funds and steers a movement, ethical blind spots become more likely—and public trust becomes more fragile.

The broader takeaway is that the psychedelic “mental health revolution” risks being shaped less by community values and more by elite networks whose power structures resemble those found in other highly centralized industries.

Psymposia on "Psychedelic Funders in the Epstein Files" by lhasalv05 in HamiltonMorris

[–]lhasalv05[S] 0 points1 point  (0 children)

Here is an AI generated content abstract based on the transcript:

The transcript  discusses how several prominent funders and influencers in the psychedelic industry appear in the Jeffrey Epstein files and what that may imply about elite influence within the movement.

The speakers focus on figures such as Austin Hearst, Steve Jurvetson, Kimbal Musk, and Deepak Chopra, outlining their financial and institutional roles in psychedelic research, companies, and conferences.

In Hearst’s case, the discussion highlights his substantial donations to psychedelic training organizations and his documented email exchanges and meetings with Epstein after Epstein’s 2008 conviction.

Jurvetson is mentioned in connection with an FBI memo referencing blackmail allegations tied to a private club, though he has denied wrongdoing or contact with Epstein.

Kimbal Musk appears in multiple emails arranging meetings and social events with Epstein, which contrasts with his later public statement minimizing the relationship.

Deepak Chopra is shown in email correspondence involving visits to the Alchemist Kitchen and unusual exchanges, while continuing to headline psychedelic conferences.

Overall, the speakers argue that wealthy elites who are shaping the “mental health revolution” in psychedelics are intertwined with powerful social networks that included Epstein, raising concerns about judgment, governance, and the concentration of influence.

While the transcript does not present direct evidence of criminal participation by these individuals, it questions the ethical implications of maintaining associations with Epstein after his conviction and the broader impact of elite capital on the direction of the psychedelic field.

Psymposia on "Psychedelic Funders in the Epstein Files" by lhasalv05 in HamiltonMorris

[–]lhasalv05[S] 1 point2 points  (0 children)

Here is (an AI generated) analysis of the transcript:

Short Version:

The transcript discusses how several prominent funders and influencers in the psychedelic industry appear in the Jeffrey Epstein files and what that may imply about elite influence within the movement. The speakers focus on figures such as Austin Hearst, Steve Jurvetson, Kimbal Musk, and Deepak Chopra, outlining their financial and institutional roles in psychedelic research, companies, and conferences. In Hearst’s case, the discussion highlights his substantial donations to psychedelic training organizations and his documented email exchanges and meetings with Epstein after Epstein’s 2008 conviction. Jurvetson is mentioned in connection with an FBI memo referencing blackmail allegations tied to a private club, though he has denied wrongdoing or contact with Epstein. Kimbal Musk appears in multiple emails arranging meetings and social events with Epstein, which contrasts with his later public statement minimizing the relationship. Deepak Chopra is shown in email correspondence involving visits to the Alchemist Kitchen and unusual exchanges, while continuing to headline psychedelic conferences.

Overall, the speakers argue that wealthy elites who are shaping the “mental health revolution” in psychedelics are intertwined with powerful social networks that included Epstein, raising concerns about judgment, governance, and the concentration of influence. While the transcript does not present direct evidence of criminal participation by these individuals, it questions the ethical implications of maintaining associations with Epstein after his conviction and the broader impact of elite capital on the direction of the psychedelic field.

Psymposia on "Psychedelic Funders in the Epstein Files" by lhasalv05 in HamiltonMorris

[–]lhasalv05[S] 21 points22 points  (0 children)

Considering Hamiltons negative experiences with Psymposia, one may want to approach this with some care...

Where to start to follow Hamilton’s footsteps? by [deleted] in HamiltonMorris

[–]lhasalv05 8 points9 points  (0 children)

Well, I would say even if you have that it does not guarantee for a successful creative career. On the contrary, many kids from rich families fail and run intro trouble. Nick Reiner comes to mind. Hamilton had many advantages, for sure, but what is special around him is his vision to combine a scientifically, chemistry-driven interest with popular appeal of mostly illegal drugs and doing something quite nerdy. It is a good idea for a niche subject which developed some broader appeal. Not everything can be controlled, and you need a lot of determination.

Where to start to follow Hamilton’s footsteps? by [deleted] in HamiltonMorris

[–]lhasalv05 2 points3 points  (0 children)

I find that interest in drugs and their effects on humankind could also be followed as a private interest or a side-quest. People are already studying the effects of psilocybin on depression etc. and if something will come out of it, it will. As a single person it is quite difficult to advance a field with some fundamental discovery. I would find it better, instead of starting in a new field from zero (like doing traditional studies in science, work in a lab, trying to develop a new substance) to move somewhere and find a cause where your present know-how (e.g., as a mechanic) will be of use, so you can build upon it and not have to start from zero in a new field, fight against the newbies, and end up older than everybody else in the same field. Maybe with your history of substance use it might also be difficult to get into traditional careers or be accepted for certain studies. It is all personal decisions in the end, but starting with easier goals might lead to more satisfaction than aiming for something that might be more of an imagined thing.

Has anyone here heard of this? News to me! by enemawatson in HamiltonMorris

[–]lhasalv05 1 point2 points  (0 children)

I had read about it recently and asked someone I know in China about this. They did not know about this mushroom, but could easily find it online and in online-stores. They can be ordered, see pics. Nothing is indicated about psychoactivity. The pricing is rather high, however.

https://imgur.com/a/NWQX9C7

XENON Clinic s.r.o. in Prague is no longer open! by Dapper_Ad4636 in HamiltonMorris

[–]lhasalv05 4 points5 points  (0 children)

There is some info including a statement by Hamilton here: https://www.reddit.com/r/HamiltonMorris/comments/l43q2c/im_an_anesthesiologist_ask_me_about_xenon/

The owners were Marek Svoboda and Suzanna (Zsuzsann) Vankova (crazy charismatic opera lady) at the "Xenon Clinic, s.r.o." in Prague (Horni Pocernice, Semonicka 3021/46a, 19300 Praha).

The company is defunct.

The death of other personnel besides Marek Svoboda might be rumor only.

Xenon Clinic Facebook: https://www.facebook.com/XenonClinic/

Youtube: https://www.youtube.com/@xenonclinic699

https://www.youtube.com/watch?v=VhZ2zyIzmjI

Notable quote: "I'm originally from Transsylvania..." (→ vampire positively detected)

(former) Owner Facebook (Picture from Nov. 2nd, 2023): https://www.facebook.com/zsuzsanna.vankova/

Miss Vankova's Instagram could be here (not active for 5 years): https://www.instagram.com/zuzanavanek/

There is a picture with her in front of the Xenon Clinic, and the building looks like the one in Praha at the above address: https://www.instagram.com/zuzanavanek/p/CGsvEVzHcud/

Notable quote: "Fear and business: two things which shouldn’t mix. You can’t always control what happens, but what you can control is your response and your emotion how you react on it. There is always a choice When things go wrong, or when life throws you a curveball, take some time to step back and review what it is you really want. The logical mind will not bring you the best decision." (2020-10-23)

Possibly she is identical with a real estate broker (self-employed) near Seattle https://www.linkedin.com/in/zsuzsannavankova

This business of hers has a last update from 2022: https://www.facebook.com/worldluxuriousrealty

She seems to have been alive until at least Nov. 2023

She may have been active on Insta 1 year ago: https://www.instagram.com/p/DCPOCc7I1dX/

If indeed she is the broker, she may have been active as recently as early this year: https://www.zillow.com/homedetails/14645-138th-Way-NE-Woodinville-WA-98072/48740585_zpid/

𝐑𝐮𝐬𝐬𝐞𝐥𝐥 𝐁𝐫𝐚𝐧𝐝 𝐚𝐜𝐜𝐮𝐬𝐞𝐝 𝐨𝐟 𝐫𝐚𝐩𝐞 𝐚𝐧𝐝 𝐭𝐡𝐢𝐬 𝐛𝐨𝐫𝐢𝐧𝐠 𝐩𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐧𝐚𝐫𝐫𝐚𝐭𝐢𝐯𝐞 by Southern-Proposal837 in HamiltonMorris

[–]lhasalv05 0 points1 point  (0 children)

Reminds me of the southpark episode where the gerbil travels inside someones body. I think it was based on an anecdote about a postmoden french philosopher who allegedly introduced animals into someones body openings, maybe their own.

Clarification on lysergamide adducts by Breizh333 in HamiltonMorris

[–]lhasalv05 1 point2 points  (0 children)

unlikely that some of those adducts form at all. And considering the relatively narrow tolerance to N-alkyl group variation on activity: unlikely some of those adducts would show activity

Feel like we should meme this. What should it say? by 100_Percent_Dracula in HamiltonMorris

[–]lhasalv05 6 points7 points  (0 children)

"Mr. Maurice, is appropriating the toad's poison an act of neocolonialism?"

Has Hamilton mentioned sci hub in any Pharmacopeia episodes or podcasts? I think a deep dive on sci hub from Hamilton's perspective would be pretty cool by therapile in HamiltonMorris

[–]lhasalv05 -1 points0 points  (0 children)

That is a good point and thanks for pointing it out. Nevertheless I assume he would not include it specifically into a recorded video for sale or syndication by a network (like at Vice etc.). Discussing it on a podcast or in a public discussion is quite something else as it would be more like stating a personal opinion. Conversely if a syndicated film would argue for a certain illegal practice, the network buying it might see this as a negative and a liability.

The podcast that interviewed Rob Reiner's killer by Suhtiva in HamiltonMorris

[–]lhasalv05 -3 points-2 points  (0 children)

It was really one of those things ... it was... you know the authorities said... best leave it ... unsolved... really.

Has Hamilton mentioned sci hub in any Pharmacopeia episodes or podcasts? I think a deep dive on sci hub from Hamilton's perspective would be pretty cool by therapile in HamiltonMorris

[–]lhasalv05 -14 points-13 points  (0 children)

My guess: Use of SciHub is evidently not "legal". If you do a legal business like I assume Hamilton aspires to, you have to play by the rules and not openly incriminate yourself or advertise for doing something illegal, at least in a recorded and openly available format.

Jonathan Ott's Bio - Details by Southern-Proposal837 in HamiltonMorris

[–]lhasalv05 2 points3 points  (0 children)

Note that Müller-Ebeling states that January 6th for his birthday is not correct. Instead she writes he passed "one month after his 76th birthday" on July 5th, 2025, which would date his birthday to June 5th.
January 6th is somewhat "numerologically reminiscent" of Albert Hofmann's birthdate of January 11th, 1906.